01—Abstract
Summary
Summary of the 8-K filed October 24, 2024. Cited figures are marked; the original filing is the authoritative source.
Morgan Stanley (NYSE: MS) disclosed in an 8-K filed October 24, 2024 that CEO Ted Pick has been elected by the Board to also serve as Chairman of the Board of Directors, effective January 1, 2025.
The change consolidates the Chairman and CEO roles under Pick, who succeeds James P. Gorman as Chairman. Gorman steps down as Chairman and leaves the Board at the end of 2024, retires from employment at the firm, and will be named Chairman Emeritus, a non-director honorary title.
The filing also discloses a post-retirement advisory arrangement with Gorman running from January 1, 2025 through the end of 2026. He will advise on matters where the firm wants to draw on his 14 years as CEO. Compensation includes an annual fee of $400,000,a continued health benefits, a car and driver, office and administrative support, and indemnification and advancement rights as an advisor under the Bylaws.
The Board may terminate the arrangement at any time or choose not to renew it. The amounts are modest relative to the firm's scale, and the arrangement is structured as a discretionary, time-limited consulting role rather than a board or executive seat. For investors, the event is largely a planned leadership transition rather than a change in strategy or financial condition.
The filing contains no financial results or guidance. The key governance points are the combined Chairman/CEO structure, which concentrates authority in one executive, and the Lead Director role held by Tom Glocer, which serves as the main check on that concentration. Investors may want to watch how the Board structures oversight under a combined role.
02—Key points
Key Highlights
- Ted Pick, current CEO, was elected by the Board to also serve as Chairman of the Board effective January 1, 2025, combining the Chairman and CEO roles.
- James P. Gorman will step down as Chairman and leave the Board at year-end 2024, retire from employment, and be named Chairman Emeritus, a non-director honorary title.
- Gorman will serve as a non-employee advisor from January 1, 2025 through the end of 2026 for an annual fee of $400,000, plus health benefits, car and driver, and office support.
- The advisory arrangement includes indemnification and advancement-of-expenses rights under the Company's Bylaws and may be terminated or not renewed by the Board at its discretion.
- Tom Glocer, Lead Director, publicly supported the transition, noting Pick's leadership and the Board's confidence in him.
- The filing contains no financial results, guidance, or material financial impact, so the event is primarily a governance and leadership development.
- Exhibit 99.1 press release reiterates the transition and notes Gorman's retirement from the firm at year-end 2024.
03—Questions
Frequently Asked Questions
Why is Ted Pick becoming Chairman while also serving as CEO?
The Board elected Pick to the additional position of Chairman, consolidating the two roles. The company's announcement cites his leadership and the Board's confidence in him. The Lead Director, Tom Glocer, is the Board's counterweight to this combined structure.
What is James Gorman's role after he leaves the Board?
Gorman will become Chairman Emeritus, an honorary, non-director title, and will serve as a non-employee advisor from January 1, 2025 through the end of 2026. He will advise on matters where the firm wants to use his experience and relationships from his 14-year CEO tenure.
What does Gorman's advisory arrangement cost the company?
The filing discloses an annual fee of $400,000, continued health benefits, access to a car and driver, and office and administrative support. He also receives indemnification and advancement rights as an advisor under the Bylaws. The Board can terminate the arrangement at any time and decides whether to renew it.
Does this leadership change affect Morgan Stanley's financial performance?
The 8-K contains no financial results, guidance, or quantified financial impact. The change is a planned succession and governance event. Investors should weigh the effects of a combined Chairman/CEO role on oversight, not any immediate financial effect.
04—Continue